Successful Treatment of Post COVID-19 Neurogenic Dysphagia with Botulinum Toxin.
Abstract
[INTRODUCTION] Dysphagia in post COVID-19 patients could be caused by several factors, including reduced pharyngolaryngeal coordination due to SARS-CoV-2 tropism to the central and/or peripheral nervous system. To our knowledge, this is the first reported case of COVID-19-related dysphagia successfully treated with botulinum toxin type A injection.
[CASE DESCRIPTION] We report the case of a patient with severe oropharyngeal dysphagia due to COVID-19 confirmed by fibre endoscopy. As a result, the patient required an enteral feeding tube. After two months of traditional swallowing therapies, there was only limited improvement. An electrophysiologic evaluation of the cricopharyngeal muscle was performed and showed a normal inhibition of the cricopharyngeal muscle, followed by a hypertonic rebound. Based on this result, we decided to perform a unilateral laryngeal injection of botulinum toxin type A. After the injection, the patient's swallowing function improved significantly, allowing him to return to oral feeding.
[DISCUSSION] Newly diagnosed oropharyngeal dysphagia was found in 35.3% of hospitalised patients with COVID-19. There are several possible causes of COVID-19-associated dysphagia, including stroke, encephalitis, critical illness neuropathy, Guillain-Barré syndrome and skeletal muscle injury. In our case, since stroke was excluded by brain MRI, cranial nerve injury was a possible explanation for the difficult recovery of swallowing despite daily swallowing therapy.
[CONCLUSION] We suggest that electrophysiology is a valid tool for the diagnosis and follow-up of patients with oropharyngeal dysphagia.
[LEARNING POINTS] SARS-CoV-2 tropism to the central and/or peripheral nervous system can cause dysphagia in post COVID-19 patients.An electrophysiologic approach is useful for the diagnosis and follow-up of patients with oropharyngeal dysphagia.A single botulinum toxin type A injection is a valid treatment option to improve the swallowing function in patients with post COVID-19 dysphagia.
[CASE DESCRIPTION] We report the case of a patient with severe oropharyngeal dysphagia due to COVID-19 confirmed by fibre endoscopy. As a result, the patient required an enteral feeding tube. After two months of traditional swallowing therapies, there was only limited improvement. An electrophysiologic evaluation of the cricopharyngeal muscle was performed and showed a normal inhibition of the cricopharyngeal muscle, followed by a hypertonic rebound. Based on this result, we decided to perform a unilateral laryngeal injection of botulinum toxin type A. After the injection, the patient's swallowing function improved significantly, allowing him to return to oral feeding.
[DISCUSSION] Newly diagnosed oropharyngeal dysphagia was found in 35.3% of hospitalised patients with COVID-19. There are several possible causes of COVID-19-associated dysphagia, including stroke, encephalitis, critical illness neuropathy, Guillain-Barré syndrome and skeletal muscle injury. In our case, since stroke was excluded by brain MRI, cranial nerve injury was a possible explanation for the difficult recovery of swallowing despite daily swallowing therapy.
[CONCLUSION] We suggest that electrophysiology is a valid tool for the diagnosis and follow-up of patients with oropharyngeal dysphagia.
[LEARNING POINTS] SARS-CoV-2 tropism to the central and/or peripheral nervous system can cause dysphagia in post COVID-19 patients.An electrophysiologic approach is useful for the diagnosis and follow-up of patients with oropharyngeal dysphagia.A single botulinum toxin type A injection is a valid treatment option to improve the swallowing function in patients with post COVID-19 dysphagia.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 4 | |
| 해부 | enteral feeding
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | laryngeal
|
scispacy | 1 | ||
| 해부 | oral
|
scispacy | 1 | ||
| 해부 | skeletal muscle
|
scispacy | 1 | ||
| 해부 | brain
|
scispacy | 1 | ||
| 합병증 | pharyngolaryngeal
|
scispacy | 1 | ||
| 합병증 | peripheral nervous
|
scispacy | 1 | ||
| 합병증 | oropharyngeal dysphagia
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION] Dysphagia
|
scispacy | 1 | ||
| 약물 | COVID-19
|
scispacy | 1 | ||
| 약물 | [LEARNING POINTS] SARS-CoV-2
|
scispacy | 1 | ||
| 기법 | endoscopy
|
내시경 | dict | 1 | |
| 질환 | Neurogenic Dysphagia
|
C1955520
Neurogenic dysphagia
|
scispacy | 1 | |
| 질환 | Dysphagia
|
C0011168
Deglutition Disorders
|
scispacy | 1 | |
| 질환 | including reduced pharyngolaryngeal coordination
|
scispacy | 1 | ||
| 질환 | COVID-19-related dysphagia
|
scispacy | 1 | ||
| 질환 | oropharyngeal dysphagia
|
C0267071
Oropharyngeal Dysphagia
|
scispacy | 1 | |
| 질환 | COVID-19-associated dysphagia
|
scispacy | 1 | ||
| 질환 | stroke
|
C0038454
Cerebrovascular accident
|
scispacy | 1 | |
| 질환 | encephalitis
|
C0014038
Encephalitis
|
scispacy | 1 | |
| 질환 | illness neuropathy
|
scispacy | 1 | ||
| 질환 | Guillain-Barré syndrome
|
C0018378
Guillain-Barre Syndrome
|
scispacy | 1 | |
| 질환 | skeletal muscle injury
|
scispacy | 1 | ||
| 질환 | cranial nerve injury
|
C0273483
Cranial Nerve Injuries
|
scispacy | 1 | |
| 질환 | COVID-19 dysphagia
|
scispacy | 1 | ||
| 기타 | COVID-19
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | Guillain-Barré
|
scispacy | 1 | ||
| 기타 | cranial nerve
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.